Bailey John E. (Jack) Jr.
Insider CIK 1806147 · GTHX President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 161,300 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 201,300 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | U Tender | 2024-09-18 | 2024-09-18 | 196,287 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer | 2024-09-18 | 2024-09-18 | 534,787 | — | $0 | 196,287 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-09-18 | 2024-09-18 | 181,400 | — | $0 | 731,074 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-07-05 | 2024-07-08 | 7,662 | $2.51 | $19.2K | 549,674 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-07-01 | 2024-07-03 | 105,000 | — | $0 | 557,336 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-05-13 | 2024-05-15 | 37,258 | $4.79 | $178.5K | 452,336 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-08 | 201,300 | — | $0 | 201,300 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-01-03 | 2024-01-08 | 9,094 | $3.12 | $28.4K | 489,594 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-08 | 100,700 | — | $0 | 501,280 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-01-03 | 2024-01-08 | 2,592 | $3.12 | $8.1K | 498,688 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2024-01-02 | 2024-01-02 | 32,983 | $3.27 | $107.9K | 400,580 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2023-07-05 | 2023-07-07 | 2,719 | $2.45 | $6.7K | 433,563 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-05-10 | 2023-05-12 | 160,000 | — | $0 | 436,282 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2023-01-04 | 2023-01-05 | 5,607 | $5.58 | $31.3K | 276,282 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 161,300 | — | $0 | 161,300 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 32,019 | $5.85 | $187.3K | 281,889 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-01-03 | 2023-01-05 | 80,700 | — | $0 | 313,908 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 204,000 | — | $0 | 204,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 34,125 | $10.41 | $355.2K | 233,208 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2022-01-03 | 2022-01-05 | 46,000 | — | $0 | 267,333 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2021-01-01 | 2021-01-05 | 320,000 | — | $0 | 320,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2021-01-01 | 2021-01-05 | 213,333 | — | $0 | 221,333 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2020-11-11 | 2020-11-13 | 4,000 | $12.83 | $51.3K | 8,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2020-11-10 | 2020-11-13 | 4,000 | $12.76 | $51.0K | 4,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2020-06-11 | 2020-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2020-03-12 | 2020-03-13 | 40,000 | — | $0 | 40,000 | SEC↗ |